Patient P-01776
Therapy response
Declining
Tolerance
Improving
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
93%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S16
- Day 31 NP-02 recommended — Dietary Support Protocol NP-02
- Day 32 Patient accepted — Started NP-02 in the companion
- Day 42 No meaningful change — Dietary Support Protocol NP-02
- Day 47 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 47.
Primary contributors, last 14 days
- Nutritional resilience-6
- Toxicity-5
- GI instability+3
- Inflammatory activity-3
What helped?
- Dietary Support Protocol NP-02Day 31Result: no meaningful change
LIFE OS recommendation
GI Support Protocol GI-04
87%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 83% showed improvement
- median effect visible after 8 days
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↓60
- MicrobiomeBacteroides fragilis expansion
- BloodInflammatory load index 63
- WearableHRV 15 ms, trending down
- Butyrate / short-chain fatty acid production ↓55
- MicrobiomeButyrate capacity 27/100
- Daily logFibre intake low in recent food logs
- Mucosal barrier integrity ↓30
- Daily logGI symptom score 67 and rising
- WearableSleep 5.4 h, below personal baseline
- Drug metabolism and exposure ↑20
- BloodToxicity index 57
- Autonomic recovery ↑20
- WearableShort sleep window
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 2.9 · butyrate capacity 27/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 16 ms
- Sleep
- 5.2 h
- Steps
- 5,940
- Resting HR
- 70 bpm
Daily log: GI score 67, nutritional resilience 31, adherence 41.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
- Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Track each bowel movement today: time, stool form, urgency, overnight waking
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- Electrolyte solution, one sachet after any loose stool
- Fictional demo item: oral nutrition supplement with lunch
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-01407 | 49% | S14 | NP-02 | no change | 44 |
| P-01492 | 49% | S15 | ME-01 | improved | 44 |
| P-01367 | 47% | S14 | GI-04 | no change | 51 |
| P-01760 | 47% | S14 | — | — | 42 |
| P-01813 | 47% | S01 | NP-02 | no change | 40 |
| P-01866 | 47% | S14 | — | — | 40 |
| P-01440 | 46% | S12 | GI-04 | no change | 51 |
| P-01582 | 46% | S14 | GI-04 | no change | 45 |
| P-01454 | 45% | S14 | GI-04 | no change | 49 |
| P-01619 | 45% | S14 | GI-04 | worsened | 38 |
| P-01797 | 45% | S14 | NP-02 | no change | 43 |
| P-01865 | 45% | S14 | NP-02 | no change | 51 |